BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10441372)

  • 1. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
    Cho HI; Park CG; Kim J
    Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate.
    Berg KL; Carlberg K; Rohrschneider LR; Siminovitch KA; Stanley ER
    Oncogene; 1998 Nov; 17(19):2535-41. PubMed ID: 9824165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
    J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase.
    Mason LH; Gosselin P; Anderson SK; Fogler WE; Ortaldo JR; McVicar DW
    J Immunol; 1997 Nov; 159(9):4187-96. PubMed ID: 9379012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.
    Binstadt BA; Brumbaugh KM; Dick CJ; Scharenberg AM; Williams BL; Colonna M; Lanier LL; Kinet JP; Abraham RT; Leibson PJ
    Immunity; 1996 Dec; 5(6):629-38. PubMed ID: 8986721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor.
    Christensen MD; Geisler C
    Scand J Immunol; 2000 Jun; 51(6):557-64. PubMed ID: 10849365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human killer inhibitory receptors: specificity for HLA-class I molecules and mechanisms of signal transduction.
    Colonna M; Döhring C; Samaridis J; Scheidegger D; Dessing M; Cella M; Campbell KS
    Transplant Proc; 1996 Dec; 28(6):3035. PubMed ID: 8962177
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone.
    Musci MA; Beaves SL; Ross SE; Yi T; Koretzky GA
    J Immunol; 1997 Feb; 158(4):1565-71. PubMed ID: 9029091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells.
    Bryceson YT; Torgersen KM; Inngjerdingen M; Berg SF; Hoelsbrekken SE; Fossum S; Dissen E
    Eur J Immunol; 2005 Apr; 35(4):1230-9. PubMed ID: 15756648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
    Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
    Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
    Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
    FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells.
    Rajagopalan S; Long EO
    J Immunol; 1998 Aug; 161(3):1299-305. PubMed ID: 9686591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.